Published 2 hours ago • loading... • Updated 2 hours ago
Jobs set to go and cancer treatments slashed in tough federal research cuts
ImmVirX says the changes would cut funding by more than $6 million a year and force staff and trial reductions.
Summary by Newcastle Herald
2 Articles
2 Articles
Reposted by
Newcastle Herald
Jobs set to go and cancer treatments slashed in tough federal research cuts
Newcastle biotech ImmVirX faces a $6 million R&D loss from Albanese government cuts. Darren Shafren comments on how this affects cancer immunotherapy patients.
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last Updated50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium




